Show
Sort by
-
Ibrutinib for first-line treatment of chronic lymphocytic leukemia in patients aged >= 65 year of age: results with 5 years of follow-up for the RESONATE-2 study
-
Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies
-
Determinants of 1-year survival in critically ill acute leukemia patients : a GRRR-OH study
-
Delayed elemination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population
-
Deguelin, a PI3K/Akt inhibitor induceds apoptotic killing of B-CLL cells in vitro
-
Differential proteome analysis of Chronic lymphocytic leukemia subtypes
-
Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia
-
Incidence, medical resource utilisation and costs of hyperuricemia and tumour lysis syndrome in patients with acute leukaemia and non-Hodgkin's lymphoma in four European countries
-
The protein expression pattern of CLL cells is stable over six months intervals
-
Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: Results of a long-term prospective study.